openPR Logo
Press release

CRBSI Treatment Market Expected to Reach USD 2.2 Billion by 2030 | Persistence Market Research

03-21-2025 09:58 AM CET | Health & Medicine

Press release from: Persistence Market Research

CRBSI Treatment Market

CRBSI Treatment Market

The global catheter-related bloodstream infection (CRBSI) treatment market is poised for significant expansion, projected to rise from US$1.5 billion in 2023 to US$2.2 billion by 2030, reflecting a CAGR of 5.7%. The market's growth is driven by the rising prevalence of chronic diseases necessitating long-term catheter use, increased healthcare expenditures, and advancements in catheter technologies.

Among the various segments, antibiotic-based treatments hold the largest share, while the echinocandin antifungal segment is expected to grow rapidly due to the rising incidence of fungal CRBSI cases. North America dominates the market, owing to its advanced healthcare infrastructure and stringent infection control measures, whereas East Asia is expected to register the highest growth rate due to increased healthcare investments and an aging population.

Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/33952

Key Highlights from the Report

The CRBSI treatment market is projected to grow at a CAGR of 5.7% from 2023 to 2030.

Antibiotics, especially vancomycin, remain the leading treatment option for CRBSI.

The echinocandin segment is witnessing rapid growth, driven by the increasing prevalence of fungal infections.

Hospital pharmacies dominate the distribution channels, but online pharmacies are gaining traction.

North America leads the market, followed by Europe, while East Asia shows the fastest growth.

Innovative catheter technologies with antimicrobial coatings are a significant market opportunity.

Market Segmentation

The CRBSI treatment market is segmented based on drug class, route of administration, indication type, and distribution channels.

By Drug Class:

Antibiotics, particularly vancomycin, hold the largest share due to their effectiveness in treating bacterial infections. Echinocandins are emerging as a high-growth segment due to their efficacy against fungal CRBSI cases.

By Route of Administration:

Injectables dominate the market, offering rapid treatment for bloodstream infections. However, oral formulations are expected to witness high growth, driven by patient convenience and improved treatment protocols.

By Indication Type:

Bacterial infections remain the largest indication segment due to the high prevalence of Gram-positive bacterial CRBSI cases. Fungal infections, though less common, are growing rapidly, driving demand for specialized antifungal treatments.

By Distribution Channel:

Hospital pharmacies account for the majority of sales, given the critical nature of CRBSI cases. However, online pharmacies are expanding quickly, offering greater accessibility to patients.

Regional Insights

North America: Market Leader

North America dominates the CRBSI treatment market due to well-established healthcare infrastructure, stringent regulatory frameworks, and high awareness levels among healthcare professionals. The U.S., in particular, sees high adoption rates for advanced antimicrobial treatments.

East Asia: Fastest-Growing Region

East Asia, led by China and Japan, is experiencing the highest market growth due to increasing healthcare investments, an aging population, and improved access to advanced treatments. Rising cases of chronic diseases requiring catheter use further drive demand.

Market Dynamics

Market Drivers

Increasing prevalence of chronic illnesses, such as cancer and kidney diseases, necessitating catheter use.

Technological advancements in catheter design, including antimicrobial coatings.

Rising healthcare expenditures improving access to better treatment options.

Market Restraints

Growing antibiotic resistance, making treatment more challenging and expensive.

High treatment costs, limiting accessibility in certain regions.

Regulatory hurdles and compliance challenges in drug approvals.

Market Opportunities

Development of antimicrobial-coated catheters to prevent infections.

Expansion of telemedicine and online pharmacies, increasing access to CRBSI treatments.

Investment in novel antibiotic and antifungal drug development to combat resistant bacterial strains.

Frequently Asked Questions (FAQs)

->How big is the global CRBSI treatment market?

->Who are the key players in the CRBSI treatment market?

->What is the projected growth rate of the CRBSI treatment market?

->What is the market forecast for 2032?

->Which region is estimated to dominate the industry through the forecast period?

Company Insights

Key Players in the CRBSI Treatment Market

Pfizer Inc.

Merck & Co., Inc.

Novartis AG

Bayer AG

Bristol-Myers Squibb

Eli Lilly and Company

AstraZeneca plc

Recent Market Developments

Pfizer announced new clinical trials focused on developing next-generation antibiotics targeting drug-resistant CRBSI strains.

Merck & Co. introduced an advanced antifungal therapy aimed at reducing fungal CRBSI cases in immunocompromised patients.

The CRBSI treatment market is on a robust growth trajectory, fueled by technological advancements, increasing catheter use, and growing awareness of infection control. With ongoing research and development efforts, the industry is set to witness significant innovation and expansion in the coming years.

Contact Us:

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release CRBSI Treatment Market Expected to Reach USD 2.2 Billion by 2030 | Persistence Market Research here

News-ID: 3929319 • Views:

More Releases from Persistence Market Research

North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
Overview of the North America Wiring Devices Market The North America wiring devices market is poised for steady growth over the forecast period, with its size estimated at US$ 18.96 billion in 2024, projected to reach US$ 26.46 billion by 2031, reflecting a CAGR of 4.9%. The market is witnessing substantial expansion due to increasing urbanization, a rising number of residential and commercial construction projects, and the adoption of energy-efficient and
Global Forged Automotive Components Market Poised for Steady Growth, Projected to Reach US$ 70.7 Billion by 2032
Global Forged Automotive Components Market Poised for Steady Growth, Projected t …
The global forged automotive components market is on a robust growth trajectory, currently valued at approximately US$ 50.3 billion in 2025 and forecasted to expand to US$ 70.7 billion by the end of 2032. This growth represents a compound annual growth rate (CAGR) of 5.0% over the coming decade, driven by increasing automotive production, technological advancements, and evolving consumer preferences toward durable, high-performance vehicle parts. Forged automotive components are critical to
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ 2.14 Billion by 2032, Reports Persistence Market Research
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ …
The global electric cargo bike market is set to experience substantial growth over the coming decade, with Persistence Market Research (PMR) forecasting a compound annual growth rate (CAGR) of 11.9% from 2023 through 2032. Valued at approximately US$ 800 million in 2021, the market is expected to surge to a projected valuation of US$ 2.14 billion by the end of 2032. Notably, electric cargo bikes accounted for 66.2% of the
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Driven by Urbanization and Demographic Trends
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Drive …
The global bicycle bearings market is poised for significant expansion over the forecast period of 2025 to 2032, according to the latest report released by Persistence Market Research. Valued at approximately US$ 5.99 billion in 2024, the market is projected to reach US$ 6.35 billion by 2025 and further escalate to nearly US$ 9.86 billion by 2032. This growth trajectory reflects a compound annual growth rate (CAGR) of 6.5%, underscoring

All 5 Releases


More Releases for CRBSI

Catheter-Related Bloodstream Infection (CRBSI) Market is expected to reach USD 3 …
Catheter-related bloodstream infections (CRBSIs) are among the most serious and common hospital-acquired infections, caused when pathogens enter the bloodstream through central venous catheters (CVCs), peripherally inserted central catheters (PICCs), or other intravascular devices. These infections significantly increase patient morbidity, hospital stays, and healthcare costs, making their prevention and treatment a top priority in modern healthcare. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71721 The market for CRBSI is expanding due
CRBSI Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment A …
DelveInsight's, "Catheter-related Bloodstream Infection -Pipeline Insight, 2025," report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Catheter-related Bloodstream Infection pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. DelveInsight reports that over five key companies are actively
Global CRBSI Treatment Market to Experience Significant Growth to reach USD 2,90 …
The global CRBSI treatment market is on a significant growth trajectory, projected to experience a compound annual growth rate (CAGR) of 5.4% between 2025 and 2035. This growth is being propelled by multiple factors, including the rising burden of hospital-acquired infections (HAIs), increased use of central venous catheters (CVC), and continual advancements in antimicrobial therapies. These key drivers, along with ongoing innovations in infection prevention and management, are expected to
Catheter-Related Bloodstream Infection (CRBSI) Drugs Market Size, Share, Growth, …
Global Catheter-Related Bloodstream Infection (CRBSI) Drugs Market to Witness Substantial Growth by 2031 The global market for Catheter-Related Bloodstream Infection (CRBSI) drugs has shown remarkable growth in recent years, reaching US$ million in 2022. According to the latest industry analysis, this market is projected to surge to US$ million by 2031, with a robust Compound Annual Growth Rate (CAGR) of during the forecast period spanning 2024 to 2031. CRBSI is
Catheter-related bloodstream infection (CRBSI) Market Insight, Epidemiology and …
Catheter-related bloodstream infection (CRBSI) Market research report is the new statistical data source added by Infinity Business Insights. CRBSIs (central venous catheter-related bloodstream infections) are a leading source of hospital-acquired illness, with high rates of morbidity, death, and expense. The severity of the consequences is determined by the organisms involved, the underlying pre-morbid states, the timeliness, and the suitability of the treatment/interventions received. Note – In order to provide more accurate
Catheter-related bloodstream infection (CRBSI) Market Insight, Epidemiology and …
Catheter-related bloodstream infection (CRBSI) Market research report is the new statistical data source added by Infinity Business Insights. CRBSIs (central venous catheter-related bloodstream infections) are a leading source of hospital-acquired illness, with high rates of morbidity, death, and expense. The severity of the consequences is determined by the organisms involved, the underlying pre-morbid states, the timeliness, and the suitability of the treatment/interventions received. Note – In order to provide more accurate